Home
Conditions
Neoplasms, Plasma Cell

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,602 public trials 545 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Recruiting

Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency

NCT05879757

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Instituto Privado de Investigaciones Clinicas de Cordoba Córdoba, Argentina

Fakultni nemocnice Plzen Pilsen, Czechia

Vseobecna fakultni Nemocnice Prague, Czechia

CHU Amiens - Hopital Sud Salouël, Somme, France

View all 27 locations

View Trial Details

Recruiting

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

NCT07410494

Conditions: Acute Myeloid Leukemia (AML), Adenocarcinoma, Adnexal Diseases, +92 more
Locations: District One Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

CAR-T Immunomonitoring in Multiple Myeloma (CART I5M)

NCT07342179

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Chu de Poitiers Poitiers, France

View Trial Details

Recruiting

Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma

NCT03909412

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Hackensack Meridian Health - John Theurer Cancer Center Hackensack, New Jersey, United States

View Trial Details

Recruiting

Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen

NCT07413809

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: The Affiliated People's Hospital of Ningbo University Ningbo, Zhejiang, China

View Trial Details

Recruiting

INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)

NCT07403630

Conditions: Acute Leukemia, Adenoma, Adnexal Diseases, +73 more
Locations: AO Riuniti Villa Sofia-Cervello di Palermo Palermo, Italy

University of Perugia Perugia, Italy

View Trial Details

Recruiting

Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.

NCT04775745

Conditions: Blood Protein Disorders, CLL/SLL, Cardiovascular Diseases, +28 more
Locations: Duke Univerisity Durham, North Carolina, United States

University of Cincinnati Cincinnati, Ohio, United States

Ohio State University Columbus, Ohio, United States

Huntsman Cancer Institute, University of Utah Salt Lake City, Utah, United States

View Trial Details

Recruiting

Study of BMS-986453 in Newly Diagnosed Multiple Myeloma

NCT07333261

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Recruiting

Study of SGR-1505 in Mature B-Cell Neoplasms

NCT05544019

Conditions: ALK-Positive Large B-Cell Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +66 more
Locations: Banner Health - MD Anderson Cancer Center Gilbert, Arizona, United States

Christiana Care Hospital - Helen F Graham Cancer Center Newark, Delaware, United States

Napa Research Pompano Beach, Florida, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View all 36 locations

View Trial Details

Recruiting

Individualized Dynamic Frailty-tailored Therapy (DynaFiT) in Elderly Patients With NDMM

NCT06099912

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Frailty, +15 more
Locations: The First Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Neoplasms, Plasma Cell

Neoplasms, Plasma Cell trial results

Related conditions